SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYPH - Cytoclonal Pharmaceutics -- Ignore unavailable to you. Want to Upgrade?


To: Emec who wrote (142)6/12/1998 6:48:00 PM
From: Axxel  Respond to of 428
 
I don't think it needs Bristol-Meyers...a deal there would be fine, but from a long-range point of view, no deal could be in CYPH's favor as well...it could be that BMY needs CYPH more than the other way around now that the drug is generic at this point...but the spotted owls can bitch like crazy...<g>



To: Emec who wrote (142)6/14/1998 10:14:00 PM
From: TokyoMex  Read Replies (2) | Respond to of 428
 
Hmmmmmm ,, let's go for a big smile tomorrow ..